Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

S&P Biotech Bear -3X Direxion (LABD)

S&P Biotech Bear -3X Direxion (LABD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
5 Best Leveraged ETFs of Last Week

Wall Street was upbeat last week. Abating banking crisis and a less-hawkish Fed led to the rally in Wall Street.

SQ : 75.31 (+1.11%)
LABD : 9.69 (-7.89%)
YINN : 23.77 (+2.41%)
MEXX : 31.58 (+1.50%)
FNGU : 314.51 (+2.93%)
GDXU : 39.63 (+2.09%)
ETF Winners From the Fed Meeting & Yellen's Testimony

Inverse ETFs surged yesterday despite the Fed's less-hawkish tone. Yellen's testimony probably have triggered the market selloffs.

LABD : 9.69 (-7.89%)
TZA : 19.56 (-2.15%)
DRV : 42.87 (-3.40%)
BNKD : 23.18 (+401.73%)
SILX : 1.7500 (unch)
FLYD : 27.07 (+0.66%)
Want Diversified Upside in Biotechnology? Check out LABU

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.

XBI : 85.52 (+2.43%)
CYTK : 62.53 (-4.30%)
LABU : 94.11 (+7.54%)
MDGL : 201.07 (+4.00%)
ARWR : 23.13 (+4.57%)
LABD : 9.69 (-7.89%)
5 Best Inverse-Leveraged ETFs of February

Wall Street gave a dismal performance last month on Fed's longer-than-expected rate hike speculation, with all three major indices in red.

LABD : 9.69 (-7.89%)
SDP : 11.08 (-2.57%)
SDOW : 17.67 (-1.12%)
NRGD : 135.72 (-1.98%)
GDXD : 24.18 (+878.95%)
5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

REGN : 892.48 (+1.05%)
BMY : 44.64 (-0.47%)
AMGN : 276.38 (+2.37%)
GILD : 65.94 (+0.79%)
IBB : 128.37 (+1.49%)
LABD : 9.69 (-7.89%)
BBH : 157.57 (+1.27%)
FBT : 145.75 (+1.46%)
PBE : 61.44 (+1.73%)
BBP : 53.45 (+2.65%)
Best Inverse/Leveraged ETF Areas of Last Week

Wall Street was downbeat last week. The S&P 500 and the Nasdaq recorded the worst week since December.

UCO : 33.67 (-1.81%)
LABD : 9.69 (-7.89%)
TZA : 19.56 (-2.15%)
NRGU : 650.47 (+1.63%)
WEBS : 6.83 (+1.94%)
FLYD : 27.07 (+0.66%)
Best Leveraged ETFs of Last Week

Wall Street was downbeat last week, probably due to the relentless market forecasts of a looming recession and an uncertain Fed rate outlook.

LABD : 9.69 (-7.89%)
TZA : 19.56 (-2.15%)
TMV : 40.15 (-2.26%)
TTT : 83.02 (-2.44%)
OILD : 13.14 (-1.94%)
NRGD : 135.72 (-1.98%)
UVIX : 8.62 (-2.82%)
5 Best Inverse/Leveraged ETFs of Last Week

Wall Street was downbeat last week. Each of the key equity gadgets -- the S&P 500 (down 0.7%), the Dow Jones (down 0.01.%), the Nasdaq Composite (down 1.6%) and the Russell 2000 (down 1.8%) -- lost last...

TSM : 138.50 (+0.14%)
SMH : 218.38 (+0.34%)
SCO : 15.65 (+1.69%)
LABD : 9.69 (-7.89%)
FYLD : 27.22 (+0.81%)
BOIL : 14.25 (+8.04%)
CWEB : 35.11 (-1.10%)
Best Inverse/Leveraged ETFs of Last Week

Wall Street was downbeat last week. Rising rate worries and recessionary fears were the key concerns.

USO : 79.50 (-1.11%)
LABD : 9.69 (-7.89%)
DRIP : 8.34 (-1.18%)
OILD : 13.14 (-1.94%)
NRGD : 135.72 (-1.98%)
WEBS : 6.83 (+1.94%)
HIBS : 25.25 (-2.06%)
FLYD : 27.07 (+0.66%)
Best Inverse/Leveraged ETFs of Last Week

Wall Street was downbeat last week on rising rate worries and FedEx'

LABD : 9.69 (-7.89%)
DRV : 42.87 (-3.40%)
TECS : 8.58 (-1.15%)
SMN : 7.40 (-1.47%)
BERZ : 28.70 (-2.88%)

Barchart Exclusives

Here's Why Novo Nordisk Stock Is a Buy Right Now
Novo Nordisk stock has surged, outperforming the market this year. Here's why it still looks like a buy right now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar